BIOR logo

Biora Therapeutics (BIOR)

Profile

Full Name

Biora Therapeutics, Inc.

Ticker Symbol

BIOR

Exchange

NASDAQ

Country

United States

IPO

June 19, 2020

Indexes

Not included

Employees

58

Key Details

Price

$0.22(0.00%)

Market cap

$994.99K(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4000.00(-98.69% YoY)

Annual EPS

-$78.70(+93.70% YoY)

PE ratio

-

Next earnings date

Apr 16, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Nov 18, 24 HC Wainwright & Co.
Buy
Aug 13, 24 HC Wainwright & Co.
Buy
Jul 22, 24 HC Wainwright & Co.
Buy
May 16, 24 HC Wainwright & Co.
Buy
Jan 2, 24 HC Wainwright & Co.
Buy
Oct 2, 23 HC Wainwright & Co.
Buy
Aug 15, 23 HC Wainwright & Co.
Buy
Jul 27, 23 HC Wainwright & Co.
Buy
May 16, 23 HC Wainwright & Co.
Buy
Jan 10, 23 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Biora Therapeutics?
  • Does Biora Therapeutics pay dividends?
  • What sector is Biora Therapeutics in?
  • What industry is Biora Therapeutics in?
  • What country is Biora Therapeutics based in?
  • When did Biora Therapeutics go public?
  • Is Biora Therapeutics in the S&P 500?
  • Is Biora Therapeutics in the NASDAQ 100?
  • Is Biora Therapeutics in the Dow Jones?
  • When was Biora Therapeutics's last earnings report?
  • When does Biora Therapeutics report earnings?
  • Should I buy Biora Therapeutics stock now?

What is the ticker symbol for Biora Therapeutics?

The ticker symbol for Biora Therapeutics is NASDAQ:BIOR

Does Biora Therapeutics pay dividends?

No, Biora Therapeutics does not pay dividends

What sector is Biora Therapeutics in?

Biora Therapeutics is in the Healthcare sector

What industry is Biora Therapeutics in?

Biora Therapeutics is in the Biotechnology industry

What country is Biora Therapeutics based in?

Biora Therapeutics is headquartered in United States

When did Biora Therapeutics go public?

Biora Therapeutics's initial public offering (IPO) was on June 19, 2020

Is Biora Therapeutics in the S&P 500?

No, Biora Therapeutics is not included in the S&P 500 index

Is Biora Therapeutics in the NASDAQ 100?

No, Biora Therapeutics is not included in the NASDAQ 100 index

Is Biora Therapeutics in the Dow Jones?

No, Biora Therapeutics is not included in the Dow Jones index

When was Biora Therapeutics's last earnings report?

Biora Therapeutics's most recent earnings report was on Nov 14, 2024

When does Biora Therapeutics report earnings?

The next expected earnings date for Biora Therapeutics is Apr 16, 2025

Should I buy Biora Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page